43 employees
Matterhorn Biosciences is a biotechnology company focusing on the discovery of cellular therapies targeting the MR1 molecule.
2020
$30M
from 1 investors over 1 rounds
Matterhorn Biosciences raised $30M on August 5, 2020
Investors: Versant Ventures